CJC-1295 W-DAC 5mg

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH), designed to extend the half-life of growth hormone stimulation. By binding to albumin through the DAC technology, this compound can remain active in the body for up to one week, making it an ideal subject for research on long-term hormonal modulation, muscle growth, recovery, and fat metabolism.

Unlike the “without DAC” version, CJC-1295 with DAC provides a continuous increase in growth hormone and IGF-1 levels, making it a key candidate in studies involving tissue repair, aging, and metabolic regulation.

How CJC-1295 with DAC Works:

• Mimics GHRH to stimulate the pituitary release of growth hormone

• DAC binds the peptide to albumin, extending its half-life to several days

• Increases circulating levels of GH and IGF-1 over time

• Designed for long-acting, stable research outcomes

Potential Benefits (Based on Preclinical Research):

• Sustained increase in GH and IGF-1 levels

• May support lean muscle growth, fat reduction, and tissue regeneration

• Reduced dosing frequency due to extended duration

• Valuable in models of aging, metabolic function, and recovery

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.